BRIEF published on 03/04/2026 at 22:35, 3 months 17 days ago DBV Technologies Announces Participation in March Investor Conferences Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 03/04/2026 at 22:35, 3 months 17 days ago DBV Technologies annonce sa participation aux conférences d'investisseurs de mars. Biopharmaceutique Conférences D'investisseurs Allergies Alimentaires Technologies DBV Patch VIASKIN
BRIEF published on 03/04/2026 at 22:35, 3 months 17 days ago DBV Technologies will participate in investor conferences in March Investor Conferences Biopharmaceutical DBV Technologies March 2026 Citizens Life Sciences
PRESS RELEASE published on 03/04/2026 at 22:30, 3 months 17 days ago DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars. La société se specialise dans le traitement des allergies alimentaires avec sa technologie exclusive VIASKIN Biopharmaceutique Conférences Investisseurs DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE published on 03/04/2026 at 22:30, 3 months 17 days ago DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies to participate in upcoming investor conferences to present its late-stage biopharmaceutical developments for food allergies. Company uses proprietary VIASKIN patch technology for treatment Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 03/03/2026 at 22:35, 3 months 18 days ago DBV Technologies: Update on voting rights and shares Euronext Paris Share Capital Voting Rights Financial Regulations DBV Technologies
BRIEF published on 03/03/2026 at 22:35, 3 months 18 days ago DBV Technologies : Mise à jour des droits de vote et actions Euronext Paris Droits De Vote Capital Social Règlement Financier DBV Technologies
BRIEF published on 03/03/2026 at 22:35, 3 months 18 days ago DBV Technologies: February 2026 Voting Rights and Shares Update Voting Rights Shares DBV Technologies NYSE Euronext Paris February 2026
BRIEF published on 03/03/2026 at 22:35, 3 months 18 days ago DBV Technologies : Mise à jour concernant les droits de vote et les actions (février 2026) Actions Droit De Vote NYSE Euronext Paris Technologies DBV Février 2026
PRESS RELEASE published on 03/03/2026 at 22:30, 3 months 18 days ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Important update on total voting rights and shares as of February 28, 2026 for NYSE Euronext Paris. Total gross voting rights: 278,352,082 Shares Total Voting Rights Regulations NYSE Euronext Paris February 28 2026
Published on 06/20/2026 at 01:00, 2 days 4 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 5 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 1 hour ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 4 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 04:05, 1 hour 53 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 8 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 23 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:33, 2 days 10 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 10 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
